Peregrine Pharmaceuticals is a biopharmaceutical company with a portfolio of product candidates in clinical trials and pre-clinical development. Its products have a focus on the targeted treatment of cancer and viral diseases. The company s product candidates are Cotara and the Tarvacin line of products. Tarvacin Anti-Viral has been developed for the treatment of hepatitis C infection, influenza and other life-threatening viral infections. Tarvacin Anti-Cancer has been developed for the treatment of solid tumor cancers. The company s tumor necrosis therapy product, Cotara, has been developed to treat malignant brain cancer. Peregrine Pharmaceutical also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, which provides development and bio-manufacturing services for both Peregrine and outside customers. Peregrine Pharmaceuticals is headquartered in Tustin, Calif.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.